Ann Arbor, MINCT05701358Now EnrollingIRB Ready

Acute Myocardial Infarction Clinical Trial in Ann Arbor, MI

Access cutting-edge acute myocardial infarction treatment through this clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.

Sponsored by Population Health Research Institute

Quick Self-Assessment

See if you qualify for this Ann Arbor location

Preparing your pre-screening questions…

Expert Care in Ann Arbor

Access acute myocardial infarction specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related acute myocardial infarction treatment provided free

Apply for This Ann Arbor Location

Check if you qualify for this acute myocardial infarction clinical trial in Ann Arbor, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Ann Arbor

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Ann Arbor site if eligible
  4. 4Begin participation

About This Acute Myocardial Infarction Study in Ann Arbor

COMPLETE-2 is a prospective, multi-centre, randomized controlled trial comparing a strategy of physiology-guided complete revascularization to angiography-guided complete revascularization in patients with acute ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel coronary artery disease (CAD) who have undergone successful culprit lesion Percutaneous Coronary Intervention (PCI). COMPLETE-2 OCT is a large scale, prospective, multi-centre, observational, imaging study of patients with STEMI or NSTEMI and multivessel CAD in a subset of eligible COMPLETE-2 patients.

Sponsor: Population Health Research Institute

Who Can Participate

Inclusion Criteria

Patients presenting with STEMI or type 1 NSTEMI and within 72 hours of successful culprit-lesion PCI
Residual coronary artery disease defined as at least 1 additional non-infarct-related coronary artery stenosis that meets all of the following criteria:
Amenable to successful treatment with PCI
At least 50% diameter stenosis by visual estimation
At least 2.5 mm in diameter
Planned complete revascularization strategy for qualifying MI

Exclusion Criteria

Planned or prior coronary artery bypass graft (CABG) surgery
Inability to clearly identify a culprit lesion for STEMI or NSTEMI based on angiographic appearance and/or ECG changes and/or regional wall motion abnormalities
Prior PCI of a non-culprit lesion in a different vessel from the culprit lesion within 45 days of randomization
Planned medical treatment of all qualifying non-culprit lesions (i.e., no PCI)
Presence of severe non-culprit-lesion stenosis with reduced epicardial flow (TIMI flow ≤ 2) or \>90% visual diameter stenosis
Presence of a chronic total occlusion (CTO) if it is the only qualifying non-culprit lesion (patients with a CTO plus additional qualifying non-culprit lesions are eligible)
The only qualifying non-culprit lesion is in the same vessel territory as the culprit lesion
Baseline STEMI or NSTEMI was due to a suspected non-atherothrombotic mechanism such as type 2 MI (supply-demand mismatch), including spontaneous coronary artery dissection or coronary artery embolism
Non-cardiovascular co-morbidity with expected life expectancy \<2 years
Any other medical, geographic, or social factor making study participation impractical or precluding 5 year follow-up

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Ann Arbor?

Yes, this clinical trial (NCT05701358) has an active research site in Ann Arbor, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Acute Myocardial Infarction Treatment Options in Ann Arbor, MI

If you're searching for acute myocardial infarction treatment options in Ann Arbor, MI, this clinical trial (NCT05701358) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Ann Arbor research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute myocardial infarction specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all acute myocardial infarction clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Ann Arbor, MI

See all heart attack clinical trials recruiting in Ann Arbor — not just this study.

Browse Heart Attack Trials in Ann Arbor →

Browse More Trials by Condition

Heart Attack TrialsMyocardial Infarction TrialsFanconi Anemia TrialsAll Conditions →

Ready to Join in Ann Arbor?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Ann Arbor, MI